⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Drug Discovery Leader Marcus Schindler Joins Cradle's Advisory Board
prnewswire.com
JNJ
ABBV
NVO
COMPUTEX 2026 Brings the Global AI Ecosystem to Taipei
prnewswire.com
MSI
INTC
TXN
NVDA
AMAT
KLAC
LRCX
MU
QCOM
AMD
GOOG
MSFT
AMZN
IBM
DELL
HPQ
VRTX
ADI
NXPI
ON
MCHP
SNPS
CDNS
MRVL
ADSK
CTAS
PAYX
ADP
CRM
NOW
PANW
FTNT
ZBRA
HON
GE
ROK
ETN
GOOGL
META
NFLX
DIS
CMCSA
T
VZ
TMUS
CSCO
ORCL
SAP
ACN
DXC
WDC
SE
SMCI
DDOG
MDB
ZS
CRWD
SNOW
PLTR
UPST
COIN
PYPL
AFRM
SOFI
HOOD
UPWK
FIVN
RBLX
EA
TTWO
U
EXAS
REGN
BIIB
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
NVO
AZN
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
VIPS
EDU
BEKE
TAL
BILI
RLX
XPEV
NIO
LI
CPT
LCID
RIVN
TSLA
GM
F
STLA
VWAGY
HOG
YETI
GOOS
LULU
UA
NKE
ANF
AEO
URBN
PVH
RL
TJX
M
BBY
WMT
COST
TGT
HD
LOW
SPG
PLD
AMT
EQIX
CCI
DLR
SBAC
AbbVie Announces Positive Topline Results from Phase 3 AFFIRM Study Evaluating SKYRIZI® (Risankizumab) Subcutaneous Induction in Patients with Crohn's Disease
prnewswire.com
ABBV
Continuous Manufacturing Market Trends and Global Forecasts, 2035 Featuring Key Players - AbbVie, Abzena, AGC Biologics, Boehringer Ingelheim, Corden Pharma, Glatt, Kaneka, Phlow, and Wuxi Biologics
globenewswire.com
ABBV
Continuous Manufacturing Market Trends and Global Forecasts, 2035 Featuring Key Players - AbbVie, Abzena, AGC Biologics, Boehringer Ingelheim, Corden Pharma, Glatt, Kaneka, Phlow, and Wuxi Biologics
globenewswire.com
ABBV
One in Three Rheumatologists View BMS’ Sotyktu as a Substantial Advance in Psoriatic Arthritis Ahead of March 6 FDA Decision, According to Spherix Global Insights Data
globenewswire.com
BMY
PFE
ABBV
AMGN
ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
globenewswire.com
ABBV
Form 8-K
sec.gov
ABBV
SPARK NS Selects Nine Projects to Receive in Total Up to $18 Million in Funding to Advance Academic Discoveries in Autism and Parkinson’s Disease from the Lab to the Clinic
globenewswire.com
NVS
MRK
BMY
LLY
ABBV
JNJ
AZN
GILD
BIIB
REGN
AMGN
VRTX
Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036
globenewswire.com
ABBV
ALC
APLS
BHC
JNJ
PFE
REGN
TEVA
VTRS